The impact of pretransplant 25-hydroxy vitamin D deficiency on subsequent graft function: An observational study

BMC Nephrology

Volumn 13, Issue 1, 2012, Pages

  Kim, Hyunwook ^a   Kang, Shin Wook ^b   Yoo, Tae Hyun ^b   Kim, Myoung Soo ^b   Kim, Soon Il ^b   Kim, Yu Seun ^b   Choi, Kyu Hun ^b  

^a Wonkwang University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; HEMOGLOBIN; SERUM ALBUMIN;

25 HYDROXYVITAMIN D DEFICIENCY; ADOLESCENT; ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PERITONEAL DIALYSIS; RENAL REPLACEMENT THERAPY; VITAMIN D DEFICIENCY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CONFIDENCE INTERVALS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; RENAL REPLACEMENT THERAPY; REPUBLIC OF KOREA; SEASONS; SERUM ALBUMIN; SEX FACTORS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84862235258     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-13-22     Document Type: Article

References (36)

1. Association of calcitriol and blood pressure in normotensive men. Kristal-Boneh E, Froom P, Harari G, Ribak J, Hypertension 1997 30 5 1289 1294 10.1161/01.HYP.30.5.1289 9369290 (Pubitemid 27476193)
2. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P, J Am Coll Cardiol 2003 41 1 105 112 10.1016/S0735- 1097(02)02624-4 12570952 (Pubitemid 36044411)
3. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, Willett WC, J Natl Canc Inst 2006 98 7 451 459 10.1093/jnci/djj101
4. Vitamin D levels and early mortality among incident hemodialysis patients. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA, Tonelli M, et al. Kidney Int 2007 72 8 1004 1013 10.1038/sj.ki.5002451 17687259 (Pubitemid 47530570)
5. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, Chiu YW, Martins D, Adler SG, Norris KC, Kidney Int 2009 76 9 977 983 10.1038/ki.2009.288 19657329
6. A vitamin D analog ameliorates glomerular injury on rat glomerulonephritis. Makibayashi K, Tatematsu M, Hirata M, Fukushima N, Kusano K, Ohashi S, Abe H, Kuze K, Fukatsu A, Kita T, et al. Am J Pathol 2001 158 5 1733 1741 10.1016/S0002-9440(10)64129-6 11337371 (Pubitemid 32422938)
7. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Agarwal R, Acharya M, Tian J, Hippensteel RL, Melnick JZ, Qiu P, Williams L, Batlle D, Kidney Int 2005 68 6 2823 2828 10.1111/j.1523-1755.2005.00755.x 16316359 (Pubitemid 43251029)
8. 1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. Kuhlmann A, Haas CS, Gross ML, Reulbach U, Holzinger M, Schwarz U, Ritz E, Amann K, Am J Physiol Ren Physiol 2004 286 3 526 F533 10.1152/ajprenal.00316.2003
9. Renoprotective role of the vitamin D receptor in diabetic nephropathy. Zhang Z, Sun L, Wang Y, Ning G, Minto AW, Kong J, Quigg RJ, Li YC, Kidney Int 2008 73 2 163 171 10.1038/sj.ki.5002572 17928826
10. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, et al. Lancet 2010 376 9752 1543 1551 10.1016/S0140-6736(10)61032-X 21055801
11. 25(OH) vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Taskapan H, Wei M, Oreopoulos DG, Int Urol Nephrol 2006 38 2 323 329 10.1007/s11255-006-0081-7 16868705 (Pubitemid 44138161)
12. Prevalence of 25(OH) vitamin D (calcidiol) deficiency at time of renal transplantation: a prospective study. Sadlier DM, Magee CC, Clin Transplant 2007 21 6 683 688 17988259 (Pubitemid 350056133)
13. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Gueorguieva R, Krystal JH, Arch Gen Psychiatry 2004 61 3 310 317 10.1001/archpsyc.61.3.310 14993119 (Pubitemid 38295833)
14. Blood calcium, phosphorus, and magnesium. Portale AA, Primer Metab Bone Dis Disord Miner Metabol 1999 5 151 154
15. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Holick MF, Am J Clin Nutr 2004 79 3 362 371 14985208 (Pubitemid 41115577)
16. Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Hollis BW, Kamerud JQ, Selvaag SR, Lorenz JD, Napoli JL, Clin Chem 1993 39 3 529 533 8448871 (Pubitemid 23099026)
17. Decreased acute rejection in kidney transplant recipients is associated with decreased chronic rejection. Matas AJ, Humar A, Payne WD, Gillingham KJ, Dunn DL, Sutherland DE, Najarian JS, Ann Surg 1999 230 4 493 498 discussion 498-500 10.1097/00000658-199910000-00005 10522719 (Pubitemid 30191844)
18. Hypovitaminosis D in medical inpatients. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, Kitch BT, Vamvakas EC, Dick IM, Prince RL, Finkelstein JS, N Engl J Med 1998 338 12 777 783 10.1056/NEJM199803193381201 9504937 (Pubitemid 28135983)
19. Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM, Am J Kidney Dis 2005 45 6 1026 1033 10.1053/j.ajkd.2005.02.029 15957131 (Pubitemid 40806515)
20. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR, Bone 2002 30 5 771 777 10.1016/S8756-3282(02)00692-0 11996918 (Pubitemid 34468001)
21. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, et al. Kidney Int 1999 55 3 1019 1027 10.1046/j.1523-1755.1999. 0550031019.x 10027939 (Pubitemid 29100714)
22. Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis. Delmez JA, Slatopolsky E, Martin KJ, Gearing BN, Harter HR, Kidney Int 1982 21 6 862 867 10.1038/ki.1982.110 6897087 (Pubitemid 12040048)
23. Loss via peritoneal fluid as a factor for low 25(OH)D3 level in peritoneal dialysis patients. Sahin G, Kirli I, Sirmagul B, Colak E, Yalcin AU, Int Urol Nephrol 2009 41 4 989 996 10.1007/s11255-009-9561-x 19404765
24. A vitamin D analog regulates mesangial cell smooth muscle phenotypes in a transforming growth factor-beta type II receptor-mediated manner. Abe H, Iehara N, Utsunomiya K, Kita T, Doi T, J Biol Chem 1999 274 30 20874 20878 10.1074/jbc.274.30.20874 10409630 (Pubitemid 29350543)
25. A retrospective evaluation of 1,25-dihydroxyvitamin D(3) and its potential effects on renal allograft function. O'Herrin JK, Hullett DA, Heisey DM, Sollinger HW, Becker BN, Am J Nephrol 2002 22 5-6 515 520 12381953 (Pubitemid 36158513)
26. Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Bhalla AK, Amento EP, Krane SM, Cell Immunol 1986 98 2 311 322 10.1016/0008-8749(86)90291-1 3489547 (Pubitemid 16112035)
27. 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Reichel H, Koeffler HP, Tobler A, Norman AW, Proc Natl Acad Sci U S A 1987 84 10 3385 3389 10.1073/pnas.84.10.3385 3033646 (Pubitemid 17085408)
28. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE, J Immunol 2007 179 3 1634 1647 17641030
29. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. Penna G, Adorini L, J Immunol 2000 164 5 2405 2411 10679076 (Pubitemid 30115468)
30. Prevention of chronic allograft nephropathy with vitamin D. Hullett DA, Laeseke PF, Malin G, Nessel R, Sollinger HW, Becker BN, Transpl Int 2005 18 10 1175 1186 10.1111/j.1432-2277.2005.00187.x 16162105 (Pubitemid 41726762)
31. Serum levels of 1,25-dihydroxyvitamin D after renal transplantation. Riancho JA, de Francisco AL, del Arco C, Amado JA, Cotorruelo JG, Arias M, Gonzalez-Macias J, Miner Electrole Metabol 1988 14 6 332 337 (Pubitemid 18261583)
32. An update on vitamin D as related to nephrology practice: 2003. Coburn JW, Kidney Int Suppl 2003 87 125 S130 14531785
33. Estimated one-year glomerular filtration rate is the best predictor of long-term graft function following renal transplant. Salvadori M, Rosati A, Bock A, Chapman J, Dussol B, Fritsche L, Kliem V, Lebranchu Y, Oppenheimer F, Pohanka E, et al. Transplantation 2006 81 2 202 206 10.1097/01.tp.0000188135. 04259.2e 16436963
34. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Wissing KM, Broeders N, Moreno-Reyes R, Gervy C, Stallenberg B, Abramowicz D, Transplantation 2005 79 1 108 115 10.1097/01.TP.0000149322.70295.A5 15714177 (Pubitemid 40140008)
35. Vitamin D3 metabolites in chronic renal failure and after renal transplantation. Lucas PA, Woodhead JS, Brown RC, Nephrol Dial Transplant 1988 3 1 70 76 3132643
36. VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome. Thiem U, Heinze G, Segel R, Perkmann T, Kainberger F, Muhlbacher F, Horl W, Borchhardt K, Trials 2009 10 36 10.1186/1745-6215-10-36 19480654